Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011
Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease Year: 2007
De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Prescribing patterns of inhaled corticosteroids in asthma amongst primary care physicians in Singapore Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021
Reduced risk for asthma exacerbations in pediatric patients receiving salmeterol plus inhaled corticosteroids (ICS) vs. ICS alone Source: Eur Respir J 2004; 24: Suppl. 48, 308s Year: 2004
Use of inhalation corticosteroids (ICS) in children with asthma in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 395s Year: 2002
Characteristics of COPD patients prescribed ICS managed in general practice vs. secondary care Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021
Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD Source: Annual Congress 2006 - COPD therapy Year: 2006
The budesonide/formoterol inhaler as maintenance and reliever therapy in Maori asthmatics Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013
Characteristics of COPD patients treated with inhaled corticosteroid in primary care Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018
Inhaled corticosteroids are over prescribed in patients with COPD, attending hospital Source: Eur Respir J 2006; 28: Suppl. 50, 429s Year: 2006
COPD guides and inhaled corticosteroids. Is there an adequate use in primary care? Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016
Predictors of adherence to inhaled corticosteroids in children with asthma and their parents in a multi-ethnic population Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma Year: 2007
Suboptimal persistence with inhaled corticosteroid (ICS) mono-therapy among children with persistent asthma in the UK Source: Eur Respir J 2006; 28: Suppl. 50, 709s Year: 2006
Characteristics and treatment pathways of patients with COPD receiving an inhaled corticosteroid/long-acting ß2-agonist (ICS/LABA) in the UK Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
The effect of smoking on severity of asthma and quality of life in patients treated with inhaled corticosteroids and long-acting b2-agonist (ICS/LABA) Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Budesonide/formoterol for the treatment of COPD exacerbations in the primary healthcare setting Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008
Asthma-related resource use and costs for patients prescribed inhaled corticosteroids compared to leukotriene modifiers in clinical practice Source: Annual Congress 2010 - Management of airway disease Year: 2010
Risk of asthma-related emergency department (ED)/hospitalization events in patients with consistent, variable or intermittent inhaled corticosteroids (ICS) Source: Eur Respir J 2005; 26: Suppl. 49, 220s Year: 2005